235 related articles for article (PubMed ID: 26972527)
1. Do patients with late-stage Parkinson's disease still respond to levodopa?
Fabbri M; Coelho M; Abreu D; Guedes LC; Rosa MM; Costa N; Antonini A; Ferreira JJ
Parkinsonism Relat Disord; 2016 May; 26():10-6. PubMed ID: 26972527
[TBL] [Abstract][Full Text] [Related]
2. Response of non-motor symptoms to levodopa in late-stage Parkinson's disease: Results of a levodopa challenge test.
Fabbri M; Coelho M; Guedes LC; Chendo I; Sousa C; Rosa MM; Abreu D; Costa N; Godinho C; Antonini A; Ferreira JJ
Parkinsonism Relat Disord; 2017 Jun; 39():37-43. PubMed ID: 28389156
[TBL] [Abstract][Full Text] [Related]
3. Disability in Activities of Daily Living and Severity of Dyskinesias Determine the Handicap of Parkinson's Disease Patients in Advanced Stage Selected to DBS.
Coelho M; Abreu D; Correia-Guedes L; Lobo PP; Fabbri M; Godinho C; Domingos J; Albuquerque L; Freitas V; Pereira JM; Cattoni B; Carvalho H; Reimão S; Rosa MM; Ferreira AG; Ferreira JJ
J Parkinsons Dis; 2017; 7(2):255-261. PubMed ID: 28157106
[TBL] [Abstract][Full Text] [Related]
4. Dysphagia predicts poor outcome in late-stage Parkinson's disease.
Fabbri M; Coelho M; Abreu D; Guedes LC; Rosa MM; Godinho C; Cardoso R; Guimaraes I; Antonini A; Zibetti M; Lopiano L; Ferreira JJ
Parkinsonism Relat Disord; 2019 Jul; 64():73-81. PubMed ID: 30902528
[TBL] [Abstract][Full Text] [Related]
5. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
[TBL] [Abstract][Full Text] [Related]
6. Levodopa Effect and Motor Function in Late Stage Parkinson's Disease.
Rosqvist K; Horne M; Hagell P; Iwarsson S; Nilsson MH; Odin P
J Parkinsons Dis; 2018; 8(1):59-70. PubMed ID: 29480220
[TBL] [Abstract][Full Text] [Related]
7. Differential progression of motor impairment in levodopa-treated Parkinson's disease.
Goetz CG; Stebbins GT; Blasucci LM
Mov Disord; 2000 May; 15(3):479-84. PubMed ID: 10830412
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease.
Ostrem JL; Ziman N; Galifianakis NB; Starr PA; Luciano MS; Katz M; Racine CA; Martin AJ; Markun LC; Larson PS
J Neurosurg; 2016 Apr; 124(4):908-16. PubMed ID: 26495947
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic-pharmacodynamic modeling of levodopa in patients with advanced Parkinson disease.
Adamiak U; Kaldonska M; Klodowska-Duda G; Wyska E; Safranow K; Bialecka M; Gawronska-Szklarz B
Clin Neuropharmacol; 2010 May; 33(3):135-41. PubMed ID: 20216409
[TBL] [Abstract][Full Text] [Related]
10. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review.
Ghika J; Villemure JG; Fankhauser H; Favre J; Assal G; Ghika-Schmid F
J Neurosurg; 1998 Nov; 89(5):713-8. PubMed ID: 9817406
[TBL] [Abstract][Full Text] [Related]
11. Speech and Voice Response to a Levodopa Challenge in Late-Stage Parkinson's Disease.
Fabbri M; Guimarães I; Cardoso R; Coelho M; Guedes LC; Rosa MM; Godinho C; Abreu D; Gonçalves N; Antonini A; Ferreira JJ
Front Neurol; 2017; 8():432. PubMed ID: 28878734
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of young onset Parkinson's disease after subthalamic stimulation--a cross-sectional study.
Tsai ST; Hung HY; Hsieh TC; Lin SH; Lin SZ; Chen SY
Clin Neurol Neurosurg; 2013 Oct; 115(10):2082-7. PubMed ID: 23916724
[TBL] [Abstract][Full Text] [Related]
13. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation.
Castrioto A; Lozano AM; Poon YY; Lang AE; Fallis M; Moro E
Arch Neurol; 2011 Dec; 68(12):1550-6. PubMed ID: 21825213
[TBL] [Abstract][Full Text] [Related]
14. The association between Parkinson's disease symptom side-of-onset and performance on the MDS-UPDRS scale part IV: Motor complications.
Bay AA; Hart AR; Michael Caudle W; Corcos DM; Hackney ME
J Neurol Sci; 2019 Jan; 396():262-265. PubMed ID: 30537631
[TBL] [Abstract][Full Text] [Related]
15. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study.
Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S
Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722
[TBL] [Abstract][Full Text] [Related]
16. Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.
Katayama Y; Kasai M; Oshima H; Fukaya C; Yamamoto T; Ogawa K; Mizutani T
J Neurosurg; 2001 Aug; 95(2):213-21. PubMed ID: 11780890
[TBL] [Abstract][Full Text] [Related]
17. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.
Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E
Mov Disord; 2007 May; 22(7):990-7. PubMed ID: 17443692
[TBL] [Abstract][Full Text] [Related]
18. Levodopa induced motor complications in Thai Parkinson's disease patients.
Kulkantrakorn K; Tiamkao S; Pongchaiyakul C; Pulkes T
J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
[TBL] [Abstract][Full Text] [Related]
19. Natural history of motor symptoms in Parkinson's disease and the long-duration response to levodopa.
Cilia R; Cereda E; Akpalu A; Sarfo FS; Cham M; Laryea R; Obese V; Oppon K; Del Sorbo F; Bonvegna S; Zecchinelli AL; Pezzoli G
Brain; 2020 Aug; 143(8):2490-2501. PubMed ID: 32844196
[TBL] [Abstract][Full Text] [Related]
20. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ
Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
